How does MyOme partner with Longevity Life?
MyOme is an end-to-end genomic testing and insights platform. That means MyOme supports the full experience, from ordering and sample processing through analysis, reporting, and ongoing support, so patients can access clinically responsible genetic insights in a way that’s built to last over time.
Why you might hear about MyOme through a partner?
Many patients first encounter MyOme through a trusted program or organization, such as:- A longevity or proactive health program (for example, Longevity Life Advisors)
- An employer-sponsored health or wellness benefit
- A benefits platform or insurance-adjacent partner that helps make testing more accessible
- A health system, clinic, or third-party organization coordinating care
- These partnerships help expand access and reduce friction, but they do not change the quality, rigor, or ownership of MyOme’s testing process.What the partnership means
When MyOme works with a partner, it typically means:
- MyOme provides the genomic testing (sequencing, analysis, and reporting)
- The partner may support things like enrollment, education, navigation, or program coordination
- Any workflows or information exchange are designed to be secure, appropriate, and patient-first
- The experience may vary slightly by program, but the core MyOme testing standards remain the same
In partnered programs, MyOme remains the genomic testing provider, responsible for the integrity of the testing experience. MyOme’s role: end-to-end genomic testing you can trust.
Regardless of how you access MyOme (through a partner, your employer, or directly), MyOme oversees:- Sample-to-report testing operations
- Quality and clinical-grade processes
- Clear reporting and results access
- Support pathways for questions and next steps